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ABSTRACT	

Neuregulin ligands and their ErbB receptors are important for the development of Schwann cells, 
the glial cells of the peripheral nervous system (PNS). ErbB3 deficiency is characterized by a 
complete loss of Schwann cells along axons of the peripheral nerves, impaired fasciculation and 
neuronal cell death. We performed comparative gene expression analysis of dorsal root ganglia 
(DRG) explant cultures from ErbB3-deficient and wild-type mice in order to identify genes that are 
involved in Schwann cell development and migration. The extracellular matrix (ECM) gene 
periostin was found to exhibit the most prominent down regulation in ErbB3-deficient DRG. 
Expression analysis revealed that the periostin-expressing cell population in the PNS corresponds to 
Schwann cell precursors and Schwann cells, and is particularly high in migratory Schwann cells. 
Furthermore, stimulation of Schwann cells with neuregulin-1 (NRG1) or transforming growth factor 
β (TGFβ-1) resulted in an upregulation of periostin expression. Interestingly, DRG explant cultures 
of periostin- deficient mice revealed a significant reduction of the number of migrating Schwann 
cells. These data demonstrate that the expression of periostin is stimulated by ErbB ligand NRG1 
and influences the migration of Schwann cell precursors.	
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INTRODUCTION	

Schwann cell precursors and PNS sensory neurons originate from the neural crest. The 
neural crest cells that are fated to participate in the formation of dorsal root ganglia (DRG) 
migrate through the rostral half of each somite and condense in repetitive units on both sides 
of the spinal cord. These nascent sensory ganglia comprise neural and glial progenitors with 
heterogeneous developmental potentialities. Upon differentiation of sensory neurons and 
axonal outgrowth, Schwann cell precursors migrate from the DRG along these projections. 
Later in development they differentiate into myelinating or non-myelinating Schwann cells 
that envelope sensory- and motor-neuron axons. The development of peripheral nerve tissue 
results from a series of coordinated interactions between neurons and Schwann cells (Jessen 
and Mirsky, 2005). Targeted mutagenesis of different components of the ErbB- signalling 
complex has demonstrated its importance for Schwann cell development (Britsch et al., 
1998; Garratt et al., 2000; Michailov et al., 2004; Riethmacher et al., 1997; Taveggia et al., 
2005). Those experiments revealed that, later in development, mutant embryos exhibit a 
total loss of Schwann cells along their peripheral axons, whereas pre-migratory Schwann 
cells are present near to the dorsal root ganglia but fail to migrate along the axons.	
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The impaired glial cell migration in these mutants indicates a direct function in migration. 
This interpretation is supported by the finding that mutations in the neuregulin–ErbB 
signalling system lead to changes in neural crest migration in mice (Britsch et al., 1998) and 
in directed Schwann cell migration in zebrafish (Lyons et al., 2005). However, an earlier 
function in fate specification and/or proliferation that could in turn be a prerequisite for 
migration cannot be completely ruled out.	

To identify components that are potentially involved in the migration process of Schwann 
cells, we took advantage of the impairment of Schwann cell migration in ErbB3-deficient 
embryos. We conducted gene expression profiling of cultured embryonic DRG [12.5 days 
post coitum (dpc)], isolated from wild-type and ErbB3-deficient embryos. Aiming to 
identify genes expressed by migrating Schwann cells, we have been focusing on genes that 
are upregulated in wild-type compared with mutant cultures, because the wild-type cultures 
are enriched for migrating Schwann cell precursors as opposed to those that are immobile. 
Periostin was one such gene that showed a higher expression in wild-type compared with 
ErbB3-deficient cultures.	

Periostin was originally isolated from osteoblasts and found to be preferentially expressed in 
the periosteum, hence the name (Horiuchi et al., 1999; Takeshita et al., 1993). Periostin 
contains an N-terminal secretory signal peptide, followed by a cysteine-rich domain, four 
internal homologous repeats and a C-terminal hydrophilic domain. The four internal repeats 
region, the fasciclin domains (Fas), exhibit homology to the axon guidance protein Fasciclin 
I that is involved in the development of nervous system in invertebrates (Zinn et al., 1988). 
Interestingly, in invertebrates, it is expressed in neurons and attached to the membrane 
through a glycosylphosphatidylinositol (GPI) anchor (Elkins et al., 1990), whereas in 
vertebrates, it is a secreted protein with a much broader expression pattern – including heart, 
periodontal ligament, fibroblasts and Schwann cells. In primary osteoblasts, periostin 
expression can be increased through stimulation with TGFβ-1 (Horiuchi et al., 1999). 
Several studies aiming to locate the protein product have revealed its presence in the ECM 
surrounding the expressing cells. In the ECM, periostin seems to be able to interact with 
several other ECM molecules, including collagen and tenascin-C (Kii et al., 2006, 2010). 
Furthermore, it has been demonstrated that periostin promotes adhesion and potentiates 
cancer cell motility by binding to integrins ανβ3 and ανβ5 (Gillan et al., 2002), and that 
forced expression of periostin induces invasive activity through epithelial–mesenchymal 
transition (EMT) in HEK- 293 cells (Yan and Shao, 2006). Several studies correlate 
periostin expression with tumour angiogenesis and metastasis in human cancer (Bao et al., 
2004; Li et al., 2007; Malanchi et al., 2011; Puglisi et al., 2008; Sasaki et al., 2001a,b, 
2003). Additionally, high pre-operative serum levels of periostin correlate with a poor 
prognosis in individuals with hepatocellular carcinoma after hepatectomy (Lv et al., 2013). 
Based on these observations, it has been suggested that periostin belongs to the group of 
matricellular proteins that are characterised as being modulators of cell-matrix interactions 
and cellular function (Kii et al., 2010; Norris et al., 2008). Interestingly, the existence of a 
non-secreted intracellular pool of periostin that is able to suppress the invasiveness of 
cancer cells, possibly by interacting with intracellular signalling molecules such as TAB1 
and Tak1, has also been described (Isono et al., 2009; Yoshioka et al., 2002). In our current 
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study, we show that periostin expression is downregulated in ErbB3-deficient DRG. In 
cultured rat Schwann cells, expression of periostin can be induced by neuregulin-1 (NRG1) 
and TGFβ-1. Additionally, we demonstrate that periostin deficiency leads to reduced 
migration of embryonic Schwann cell precursors and that recombinant periostin is able to 
promote cellular motility.	

RESULTS  
Genes expressed in migrating Schwann cell precursors  
In order to identify genes that are potentially involved in Schwann cell precursor migration, 
we performed DNA microarray expression analysis with DRG explant cultures of ErbB3-
deficient embryos. In mutant cultures, the migration of Schwann cell precursors along the 
axons did not occur, yet axonal outgrowth and neuronal survival in these cultures was not 
impaired (Fig. 1A). At 12.5 dpc, the DRG of ErbB3-deficient and wild-type embryos were 
isolated. Following 36 h of in vitro culture, the explant cultures were harvested, RNA was 
isolated and then used to hybridize Affymetrix MicroArray (probe sets MG-U74Av2, MG-
U74Bv2 and MG-U74Cv2). After evaluation of the obtained data sets, 176 genes were 
found to exhibit a significantly higher expression in samples that had been derived from 
wild-type DRG cultures, in contrast, only nine genes showed increased expression in 
samples from ErbB3-deficient DRG. To further analyse the data, we grouped the 
differentially expressed genes into functional categories. The three major groups were 
transcription-related proteins, ECM proteins and nuclear proteins (Fig. 1B). However, when 
we focused our analysis on genes that exhibited the most significant increases in expression 
in wild-type DRG (top 20 of the list), 36% (7 out of 20) could be assigned to the group of 
the ECM proteins (Fig. 1C).	

Fig. 1. Microarray analysis of DRG explant 
cultures of wild-type and ErbB3-deficient mice. 
(A) DRG explant cultures of wild-type (+/+) and 
ErbB3-deficient mice (−/−) were isolated from 
embryos at 12 dpc, cultured for 72 h and imaged 
under a microscope using phase contrast. Note the 
absence of migrating Schwann cells in the DRG 
culture from ErbB3−/− animals. Scale bar: 50 μm. 
(B) All genes with a higher level of expression in 
wild-type DRG were grouped into functional 
categories. (C) Twenty genes with the highest 
differential expression were grouped into classes. 
Note the high percentage of ECM molecules (7 
out of 20, 35%). (D) Virtual northern blot of 
mRNA isolated from DRG explant cultures of 
wild-type (+/+) and ErbB3-deficient mice (−/−). 
The periostin-specific transcript was detected 
through hybridisation with a radioactively labelled 
periostin-specific probe. GAPDH was detected 
accordingly and was employed as a loading 
control.	

The most prominent differential expression was detected for the ECM molecule periostin. 
To verify and further support this finding, we next compared expression levels by using 
other approaches. A virtual northern blot analysis employing the total RNA of DRG explant 
cultures derived from wild-type and ErbB3-deficient cultures confirmed the lower 
expression levels of periostin in ErbB3-deficient cultures (Fig. 1D). Moreover, quantitative 
real-time PCR (qRT-PCR) analysis revealed a 10.5-fold higher expression of periostin in 
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samples derived from wild type compared with those from mutant cultures (data not 
shown). As the most prominent difference between wild-type and ErbB3-deficient DRG 
cultures is the population of migrating Schwann cell precursors, these results point towards 
expression in these cells and also suggest a potential role of periostin for the migration 
process of these cells. 	

Periostin expression in Schwann cells	

We therefore analysed the expression pattern of periostin during embryonic development by 
using in situ hybridisation of wild-type embryos at different stages. Prominent periostin 
expression is detectable in a variety of tissues and organs including bone, cartilage, heart 
and tongue as early as 10.5 dpc. At this stage of development, neural crest cells have already 
migrated out of the neural tube, and DRG formation has been initiated. Periostin expression 
was readily detectable in DRG at this early stage (Fig. 2A), and expression within DRG 
persists throughout embryonic development (Fig. 2B,C). At 12.5dpc, strong expression of 
periostin could additionally be detected along axonal projections (Fig. 2D). To further 
characterise the expression pattern, we made use of a mouse mutant in which the β-
galactosidase open reading frame had been fused in frame to the ATG start codon of the 
periostin gene, thereby replacing most of exon 1 and exon 2, resulting in a frameshift (the 
generation of these mice will be described elsewhere). Heterozygous animals were 
phenotypically normal but expressed the β-galactosidase gene within the cells that 
expressed periostin.	

"
Fig. 2. Expression analysis of periostin in DRG. 
(A–D) Periostin expression during development 
was followed by using in situ hybridisation with 
a 35S-labelled periostin-specific probe on 
sagittal sections of wild-type embryos at 
different stages. Expression in several 
connective tissues, the periosteum and the 
valves of the heart has been previously 
described. Also note the strong expression in the 
umbilical cord, highlighted with an asterisk 
(A,B).	

(A) Expression at 10.5 dpc. Note the expression 
in the DRG, indicated by arrows. (C) 
Expression at 16.5 dpc shows that the robust 
expression within the DRG persists (arrows). 
(B,D) Expression at 12.5 dpc. D is a higher 
magnification of the boxed area in B. Note the 
higher expression along axonal projections 
(arrowheads) compared with the expression 
level within the DRG (arrows). Scale bars: 250 
μm (A); 500 μm (B,C); 125 μm (D).	

Journal of Cell Science (2015) 128, 3345ff  5
Co-immunofluorescence analysis of heterozygous embryos at 12.5 dpc with antibodies 
specific for β-galactosidase and Sox10, a marker for glial cells in the PNS, confirmed the 
expression of periostin in the glial cell population (Fig. 3A–C). To examine the expression 
pattern of periostin in DRG explant cultures, we performed a co- immunofluorescence 
analysis that employed antibodies against Sox10 and periostin. Sox10-positive cells were 
found to exhibit robust periostin expression (Fig. 3D–F). Interestingly, even though the 
majority of the protein is secreted and can be detected in and purified from the supernatant, 
periostin was also detected within the cells.	

Different isoforms of periostin varying within the 3ʹ′-translated region have been described 
(Horiuchi et al., 1999; Litvin et al., 2004). Interestingly, exon 17 has not been included in 
the official periostin cDNA or protein sequences; however, it is present in the genome 
sequence releases and thus should be included. Exon 17 has been described by Litvin et al. 
as only being present in the isoform periostin-like factor (PLF) (Litvin et al., 2004), whereas 
Kyutoku et al. correctly state it to be part of the periostin coding region (Kyutoku et al., 
2011). To assess the presence of different periostin isoforms in glial cells of the PNS, we 
generated cDNA from DRG. Amplification by using gene-specific primers and subsequent 
sequence analysis revealed the expression of five different isoforms in embryonic glial cells, 
one of which (isoform IV) was previously unidentified (Fig. 4). We were able to detect a 
full-length transcript (containing all 23 exons) and several variants where either exon 21 
(isoform II) or 17 (isoform III) were absent, or a combination of exons 17 and 20 (isoform 
IV) or exon 17, 20 and 21 (isoform V) were absent (Fig. 4).	

Relocalisation of periostin through neuregulin-1 and stimulation of periostin transcription in 
Schwann cells  
As we identified periostin in our screen as being upregulated in wild-type DRGs compared 
with ErbB3-deficient DRGs, we next investigated whether the neuregulin–ErbB signalling 
system has any direct influence on periostin expression levels. For these experiments, we 
used the S16 Schwann cell line, which closely corresponds to Schwann cells at an early 
stage of myelination (Toda et al., 1994). These cells express the ErbB receptors and are 
responsive to NRG1 (data not shown). S16 cells were grown either on laminin or on poly-
Fig. 3. Co-expression of periostin and Sox10 in DRG 
and DRG explant cultures. (A–C) Periostin expression 
in DRG was analysed by using immunohistochemistry 
analysis of sagittal sections of heterozygous periostin- 
mutant embryos at 12.5 dpc. (A) To identify cells that 
expressed periostin, we made use of the β-galactosidase 
(green) expression, which reflects the periostin 
expression in heterozygous periostin mutants. Note that 
the β-galactosidase remained within the expressing 
cells in contrast to periostin, which was secreted. (B) 
Glial cells were identified through expression of the 
glial marker Sox10 (red). (C) An overlay of the images 
in A and B is shown. Note the strong expression of 
periostin (β-galactosidase) in the area of the nerve root	

(arrows). (D–F) Periostin expression in DRG explant cultures was assessed by co-immunostaining with antibodies against periostin 
(green, D) and Sox10 (red, E). An area several millimetres away from the ganglia, where mostly migrating Sox10-positive Schwann 
cells are located, is shown. (F) An overlay of the images in D and E is shown. Note the substantial overlap of Sox10 and periostin 
expression in migrating Schwann cells. Scales bars: 100 μm (A–C); 10 μm (D–F).
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DL-ornithine (PDO), and left unstimulated or were stimulated with NRG1. In cells grown 
on PDO, non-secreted periostin localized in the centre of the cytoplasm, surrounding the 
nucleus (Fig. 5A), whereas in cells grown on laminin, periostin was observed mainly at the 
protrusions of the cells (Fig. 5C). Interestingly, upon stimulation with NRG1, expression 
levels appeared to be upregulated and the protein localized at cellular protrusions, whether 
cells were grown on PDO or laminin (Fig. 5B,D). Thus, the stimulation with NRG1 of S16 
Schwann cells that had been grown on PDO resulted in a relocalisation of periostin, 
reminiscent of the localisation of the protein that was observed when cells were grown on a 
migration-promoting surface such as laminin.	

To assess the impact of NRG1 stimulation on periostin expression levels, we performed a 
qRT-PCR analysis. S16 cells were cultured until they were semi-confluent and then 
stimulated with NRG1, TGFβ-1 or a mixture of both factors. TGFβ-1 is a known stimulator	

of periostin expression in a variety of cell types (Horiuchi et al., 1999; Tai et al., 2005). 
Stimulation with NRG1 resulted in an almost fivefold increase of periostin expression, 
whereas stimulation with TGFβ-1 resulted in a sixfold increase compared with that of 
unstimulated cells (Fig. 5E). Interestingly, we observed an 11-fold increase of periostin 
transcription levels upon combined stimulation with both NRG1 and TGFβ-1 (Fig. 5E), 
suggesting that the ErbB3 ligand NRG1 and TGFβ-1 cooperate to upregulate periostin 
expression in S16 Schwann cells.	

Periostin interacts with laminin and a variety of ECM molecules  
Periostin is known to interact with collagen I (Norris et al., 2007), as well as other ECM 
molecules such as fibronectin, tenascin-C and collagen IV (Kii et al., 2010; Takayama et al., 
2006). The relocalisation of periostin in S16 Schwann cells that had been cultured on 
laminin prompted us to investigate whether periostin and laminin can interact directly. In 
order to test such a potential interaction, a His10- and c-Myc double-tagged recombinant 
Fig. 4. Periostin isoforms in wild-type DRG 
explant cultures. (A) Nucleotide sequence of 
the C-terminal domain of murine periostin. 
Exons 16 to 23 (up to the stop codon) are 
shown. The exons are boxed and alternate 
between white (even) and grey (odd). The 
exon lengths (number of nucleotides) are 
indicated in brackets. Note that excision of 
any exon from exon 17 to exon 22 does not 
induce a frameshift. (B) Isoforms identified in 
wild-type DRG explant cultures are shown, 
depicting exon composition, length and 
calculated molecular mass. For this analysis, 
mRNA of DRG explant cultures that had been 
cultured for 3 days was isolated, then cDNA 
was generated and amplified with specific 
primer sets F15 (forward primer exon 15) and 
R23 (reverse primer exon 23), subcloned and 
sequenced. In all variants, exons 16, 18, 19, 
22 and 23 were present. Note that variant IV 
has not been described before.
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periostin construct (isoform I, full length) was expressed in HEK- 293 cells and purified to 
homogeneity from cellular supernatants by using Ni2+-affinity chromatography, as assessed 
by using SDS- PAGE and western blotting (Fig. 6A). Solid-phase binding assays 
demonstrated a robust interaction of recombinant periostin with laminin and a less 
pronounced interaction with collagen I and fibronectin (Fig. 6B). This interaction was 
dependent on the presence of Ca2+ because without added Ca2+, no specific interaction could 
be detected (data not shown). We were unable to observe any specific interaction with 
collagen IV (Fig. 6B). To further corroborate this interaction between periostin and laminin, 
we performed co-immunoprecipitation experiments with periostin-expressing cells and 
exogenously added laminin. In these experiments we were able to co-precipitate periostin 
by using laminin-specific antibodies (Fig. 6C). Having demonstrated the potential of the two 
proteins to physically interact, we determined their location in developing nerves. We were 
able to co-localise both proteins in developing nerves by employing sections of DRG and 
spinal nerves from 12.5-dpc embryos (Fig. 7A). Co-localization and the ability to physically 
interact indicate that there is a functional interplay between the two molecules in vivo.	

"
Periostin stimulates migration of Schwann cell precursors and HEK-293 cells  
Because we discovered periostin in an expression analysis that aimed to identify genes 
which are potentially involved in Schwann cell migration, we next examined the effect of 
periostin expression on Schwann cell migration. To this end, we used embryonic DRG 
cultures from periostin-deficient and wild-type mice and compared Schwann cell migration. 
Several groups, including ours, have independently generated periostin-deficient animals 
(Kii et al., 2006; Oka et al., 2007; Rios et al., 2005) (A. Brodarac, Impaired tooth 
Fig. 5. Expression analysis of periostin in S16 
Schwann cells. (A–D) Periostin expression in S16 cells 
was analysed by using immunocytochemistry with a 
periostin-specific antibody (red). Nuclei were visualized 
by Hoechst 33342 staining. S16 cells were plated on 
poly-DL- ornithine (PDO)- (A,B) or laminin-coated 
(C,D) dishes, cultured with serum- free medium and 
then treated with 10 ng/ml NRG1 (Nrg) for 4 h (B,D) or 
the treatment with NRG1 was omitted (unstimulated) 
(A,C). Note the relocalisation of periostin upon NRG1 
stimulation on PDO (B). Expression of periostin 
appears to be upregulated upon stimulation with NRG1 
on both substrates. Scale bar: 10 μm (A–D). (E) To 
analyse the upregulation in more detail, S16 cells were 
plated on laminin-coated dishes, cultured with serum-
free medium and stimulated for 24 h with 10 ng/ml 
NRG1 (Nrg) or 1 ng/ml TGFβ-1 (TGFβ), a known 
stimulator of periostin expression in a variety of cell 
types. Periostin transcript levels were analysed by using 
qRT-PCR for three independent experiments. A strong 
and significant increase in periostin expression could be 
observed after stimulation with NRG1, TGFβ-1 or 
stimulation with both (Nrg/TGFβ) compared with that 
of unstimulated cells (unstim.). Significance is indicated 
as *P<0.05, **P<0.01, ***P<0.001.
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development in periostin deficient mice, PhD thesis, University of Hamburg, 2006). These 
mice do not show any overt phenotype during embryonic development, and the gross 
development of the PNS appears normal in the absence of periostin expression. 	

	

Interestingly, when we analysed DRG 
cultures, we observed severely reduced 
migration of Sox10- positive Schwann cells 
in periostin-deficient cultures compared with 
that in wild-type cultures, whereas the axon 
outgrowth was not impaired (Fig. 7B). To 
Fig. 6. Interaction of periostin with ECM molecules. (A) 
Periostin comprising a C-terminal His-tag and an additional c-
Myc epitope was expressed in HEK-293 cells and purified by 
using Ni2+ affinity chromatography. Coomassie-stained SDS-
PAGE and immunoblotting using a Myc-specific antibody 
revealed a protein with a molecular mass in the expected range 
of slightly above 90 kDa. (B) Interaction of periostin with 
ECM molecules was analysed by using a solid-phase assay. 
100 μg/ml of the ECM molecules were coated onto 96-well 
plates and incubated with 50 μg/ml recombinant periostin in 
the presence of Ca2+ in the binding buffer. Interaction of 
periostin was detected using an anti-c-Myc HRP conjugate and 
visualized using ABTS as a substrate. Note that the interaction 
was Ca2+-dependent as binding in the absence of Ca2+ was 
below the control level and did not vary between the different 
ECM molecules. Significance is indicated as **P<0.01, 
***P<0.001. FN, fibronectin; Lam, laminin; Col, collagen 
(isoforms IV and I, respectively). (C) Co-immunoprecipitation 
of laminin (Lam.) and periostin (Per.) was performed in mock 
(−) or periostin (+) transfected HEK-293 cells. Laminin (+) 
was added to the supernatant and complexes were precipitated 
using a laminin-specific antibody. The interaction was 
assessed by immunoblotting and detection of precipitated 
periostin with a Myc-specific antibody. The control lanes (c) 
represent the input before immunoprecipitation, whereas the 
‘IP’ lanes show the results after immunoprecipitation.	

Fig. 7. Colocalisation and influence on migration. (A) 
Immunostaining of cryosections from a 12.5-dpc embryo 
showing the area of the thoracic DRG with periostin- (green) 
and laminin-specific (red) antibodies. Note the substantial 
overlap of the expression domains, both within the DRG and 
along the axonal projection. (B) Immunostaining of DRG 
explant cultures derived from wild-type and periostin-deficient 
embryos (12.5 dpc) using the Neurofilament200 (Nf200, green) 
antibody and an antibody specific for Sox10 (red). Axonal 
projections (lengths and numbers) are comparable between 
genotypes, whereas the number of migrating Schwann cell 
precursors (Sox10 positive) is clearly reduced in periostin-
deficient cultures. Nf200/Sox10, co- staining of neurofilaments 
and Sox10. Scale bars: 100 μm (A,B).
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characterise this in more detail, we monitored migration in several independent cultures 
from wild type, and heterozygous and homozygous periostin mutants. Schwann cell 
migration in cultures from heterozygous mutants was normal, whereasin cultures from 
periostin-deficient embryos, we observed a 50% reduction in migration (Fig. 8A). Attempts 
to rescue mutant cultures by either prior coating of the dishes with periostin or by adding it 
to the medium were not successful (data not shown). We next analysed whether periostin 
deficiency has any impact on Schwann cell proliferation or apoptosis in these cultures as 
this would also affect the outcome of our migration analysis. However, proliferation and 
apoptosis rates in wild-type and periostin-deficient DRG cultures showed no significant 
differences (Fig. 8B). The finding that neither proliferation nor apoptosis were affected in 
these cultures clearly suggests that periostin has a direct impact on the migratory capacity of 
Schwann cell precursors.	

"
Fig. 8. Influence of periostin on migration. (A) DRG explant 
cultures from periostin deficient (−/−), heterozygous (+/−) or 
wild-type (+/+) embryos  
(12.5 dpc) were cultured for 72 h and stained with an antibody 
against Sox10 (red) to visualise the Schwann cells (see Fig. 7B). 
The Sox10-positive migrating cells per DRG were counted in all 
DRG that had adhered to the coverslip and divided by the 
number of DRG. The mean number of wild-type cultures was 
taken as 100% migration and compared with the mean numbers 
of heterozygous and periostin-deficient cultures. Wild-type and 
heterozygous cultures showed very similar values, whereas a 
significant difference (***P<0.001) became apparent in 
periostin-deficient cultures. (B) Proliferation and apoptosis. 
Proliferation was followed by treatment of the DRG explant 
cultures with BrdU for 1 h. Apoptosis was monitored by 
applying the TUNEL method. Schwann cells were visualized by 
using a Sox10-specific antibody. The cells positive for both 
BrdU and Sox10, or TUNEL and Sox10 were counted and 
related to the total number of Sox10-postitive cells. No 
significant differences could be detected. (C) Boyden chamber 
assay. Conditioned medium from HEK-293 cells that either 
stably expressed periostin (CM+Periostin) or did not express 
periostin (CM−Periostin) was added to the lower well of a 
chemotactic chamber. Either periostin (Hek-Periostin) or mock 
transfected (Hek-EGFP) HEK-293 cells were plated at 
equivalent densities on the membrane of the upper chamber. 
After 48 h, the membrane was stained and the cells counted. (D) 
Several independent assays were performed and statistically 
analysed. All observed differences were highly significant 
(***P<0.001, not indicated in graph for clarity). The highest 
migration activity was observed in experiments when mock-
transfected cells were assayed in the presence of periostin in the 
conditioned medium (white box). These values were taken as 
100% and compared with the other values. Interestingly, cells 
expressing periostin that had been assayed in the presence of 
periostin in the conditioned medium (light grey) just reach 80% 
(*P<0.05), suggesting that very high levels of periostin might 
impede migration. Note that cells expressing periostin are able 
to migrate in this assay, even when no periostin was added in the 
conditioned medium (dark grey), whereas no migration was 
detected when non-expressing cells were assayed in the absence 
of periostin in the medium (black).
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Because periostin has been implicated in migration processes in a variety of cell types and 
different contexts (i.e. cancer, cutaneous wound healing), we wanted to support our 
observations of DRG cultures by employing another experimental setup. Therefore, 
periostin- or mock-transfected HEK-293 cells were analysed in a Boyden chamber assay 
using conditioned medium from these cells or control medium that did not contain any 
periostin (Fig. 8C). In this experimental setup, conditioned medium containing periostin 
strongly stimulated the migration of HEK-293 cells. Interestingly, migration was highest 
when cells were exposed to periostin but did not express it endogenously (Fig. 8D), and the 
observed migration in this experimental setup was regarded as 100%. Periostin-expressing 
HEK- 293 cells exhibited a slightly lower migration rate (80%). When no periostin was 
present in the medium, mock-transfected (EGFP) control cells were stationary, whereas 
periostin-expressing cells were still able to migrate (40%) (Fig. 8D). To assess whether this 
higher migration rate was accompanied by higher rates of proliferation of these cells, which 
might influence the migration behaviour, a BrdU labelling experiment was performed. 
Again, we were unable to detect any changes in the proliferation rates (data not shown). 
These findings and the results obtained using DRG cultures clearly indicate that periostin 
can increase the migratory capacity of cells.	

DISCUSSION	

Considerable progress has been made in the identification of molecules involved in neural 
crest cell development and in understanding their impact on processes – including 
proliferation, differentiation and de-differentiation (Crane and Trainor, 2006; Dupin et al., 
2007). However, there is only scarce knowledge of the molecules involved in Schwann cell 
migration. One important player in neural crest and Schwann cell development is the 
neuregulin–ErbB signalling system (Newbern and Birchmeier, 2010). DRG explant cultures 
of ErbB3-deficient embryos reflect the migration impairment of the Schwann cell precursor 
(Riethmacher et al., 1997) and therefore represent an ideal model for expression analyses of 
the genes that are involved in migration when compared with those of wild-type cultures. 
Our microarray analyses revealed a prominent differential expression of ECM molecules, 
which is independently supported by microarray data that has been collected using isolated 
neural crest stem cells and Schwann cell precursors (Buchstaller et al., 2004). The highly 
differential expression of ECM molecules coincides with axonal growth and the on-going 
process of Schwann cell precursor migration along the axons, suggesting a potential 
involvement of such ECM components in these processes. Furthermore, ECM molecules 
and their receptors have been implicated in Schwann cell development and function 
(Chernousov et al., 2008), as well as migration (Chernousov et al., 2001; Milner et al., 
1997). The ECM protein periostin, which exhibited the most significant differential 
expression in our microarray analysis, is expressed in a variety of tissues during 
development, including DRG and Schwann cell precursors, as shown by us and others 
(Kruzynska-Frejtag et al., 2001; Lindsley et al., 2005).	

So far, several isoforms of periostin with varying domain compositions in the C-terminus, 
generated through alternative splicing, have been reported (Horiuchi et al., 1999; Litvin et 
al., 2004; Ozdemir et al., 2014). Using RNA that was isolated from DRG cultures, we could 
identify five different isoforms, including an isoform that has not been described previously. 
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The exact function and physiological relevance of the different isoforms remain elusive. 
However, because periostin has been implicated in a variety of different, partially even 
conflicting, functions (Bao et al., 2004; Kim et al., 2005; Shao et al., 2004), alternative 
splicing might offer an explanation for these findings. Similarly, the different isoforms 
present in the precursor and migrating Schwann cells might have varying impacts on 
cellular behaviour – e.g. motility. Further experiments are required to investigate how 
different compositions of the C-terminus influence the ability to interact with other ECM 
molecules or receptors. In this context, it will also be interesting to determine the expression 
levels of the different splice variants.	

In order to identify the biological functions of periostin, several labs have independently 
generated periostin-deficient mice. Surprisingly, despite the robust expression during 
embryonic development, mutants show apparently normal development and are viable, 
indicating that there is a backup mechanism for periostin function in its absence. The most 
apparent phenotype is impairment of the eruption of incisors, which first presents itself 
shortly after weaning (A. Brodarac, Impaired tooth development in periostin deficient mice, 
PhD thesis, University of Hamburg, 2006) and causes secondary defects such as 
malnutrition and dwarfism (Kii et al., 2006; Rios et al., 2005). More recent studies involving 
different challenging strategies have revealed subtle defects in skin, tendons, heart valves, 
and changes in regeneration dynamics following myocardial infarction (Norris et al., 2008, 
2007; Oka et al., 2007; Shimazaki and Kudo, 2008; Snider et al., 2008). Interestingly, subtle 
phenotypes during normal development and impairment of tissue remodelling and repair are 
hallmarks of mice carrying targeted mutations in other matricellular proteins (Bornstein and 
Sage, 2002).	

Although Schwann cell development is normal in periostin- deficient animals, in this paper 
we were able to show that cultured DRG of periostin-deficient animals could not sustain 
Schwann cell migration at levels comparable to those of wild-type DRG. During 
development, there is most likely to be an alternative mechanism operating in the absence of 
periostin that is not present in our DRG culture. This experimental setup shows that 
periostin can be involved in cell migration. Our Boyden chamber assay further showed that 
the concentration and localisation of periostin is also important for its migratory function. 
We therefore conclude that periostin can influence the migratory behaviour of Schwann 
cells and also other cells, but in the absence of periostin, other proteins – i.e. murine TGFBI 
– can compensate for its function during embryonic development. Interestingly, our 
preliminary data indicate that the absence of periostin leads to delayed and reduced 
regeneration after peripheral nerve injury (E.S.-R. and D.R., unpublished data). We show 
here that paracrine expression alone enhances migration compared with simultaneous 
paracrine and autocrine expression (Fig. 8D). However, if no paracrine expression is 
present, cells expressing periostin in an autocrine fashion are more likely to migrate than 
cells that lack periostin. The migratory function is also interesting with respect to expression 
of periostin in tumour development and metastasis. The ability of tumour cells to migrate 
and invade other tissues is an important prerequisite for the development of metastasis 
(Hanahan and Weinberg, 2000). Papers with conflicting results have been published 
showing that upregulation as well as downregulation of periostin can lead to a more severe 
tumour phenotype and to enhanced metastasis (Kim et al., 2005; Malanchi et al., 2011; 
Journal of Cell Science (2015) 128, 3345ff  12
Morra and Moch, 2011). This leads us to propose a model in which the periostin expression 
levels of the tumour itself, the periostin expression levels of the surrounding tissue and the 
periostin levels in the serum cooperatively influence the metastatic potential of a tumour.	

We showed that the expression levels of periostin are not only influenced by TGFβ-1, as 
previously shown (Horiuchi et al., 1999), but also by NRG1. Additionally, the interaction of 
the two ligands results in a higher expression level than either ligand on its own (Fig. 5E). 
Experiments using different conditions have shown that the neuregulin signalling and 
TGFβ-1 can cooperate to influence the invasiveness of cancer cells (He et al., 2011), and 
also in peripheral nerve regeneration (Ribeiro-Resende et al., 2009). Both of these studies 
suggest the existence of cooperative, synergistic effects for TGFβ-1 and neuregulin 
signalling. From our results, it is very possible that these effects are mediated through 
periostin. In recent experiments, it has been shown that Wnt5a can also upregulate periostin 
expression but seems to exert this upregulation solely through augmentation of TGFβ-1 
levels (Hasegawa et al., 2015). The connection between neuregulins and the expression 
level of periostin, as well as our preliminary data on nerve regeneration, are exciting as a 
recent paper shows that re-expression of neuregulins after injury to Schwann cells is highly 
important for regeneration and remyelination (Stassart et al., 2013).	

Our results show that periostin exists in a variety of isoforms and that its expression levels 
are influenced cooperatively by different ligands of receptor kinases. Furthermore, periostin 
can interact with different ECM molecules, and these interactions are most likely to affect 
the localisation of periostin. Therefore, this study suggests that periostin is a protein that is 
involved in cell motility, the exact function of which can be fine-tuned through expression 
levels, interaction partners and also possibly different isoforms.	

MATERIALS AND METHODS  
Transgenic mice 
Generation, maintenance and genotyping of mice heterozygous for a deletion in ErbB3 has been 
described previously (Riethmacher et al., 1997), whereas generation and genotyping of periostin-
deficient mice will be described elsewhere (A. Brodarac, Impaired tooth development in periostin 
deficient mice, PhD thesis, University of Hamburg, 2006). All animals in Hamburg were cared for 
according to the ‘Guide for the Care and Use of Laboratory Animals’ prepared by the National 
Academy of Sciences and published by the National Institutes of Health (NIH; publication 86-23 
revised 1985), and experiments involving animals bred in Southampton were performed under a 
Home Office Licence and in accordance with the Animals (Scientific Procedures) Act, 1986, UK.	

DRG cultures	

Heterozygous mutant animals were mated, and pregnant females euthanized at 12.5 dpc. The 
embryonic DRG were dissected and grown in a defined medium that has been used previously for 
embryonic mouse neurons (Davies, 1998). Genotyping was performed using standard techniques 
with the following primers – ErbB3 forward-1 5ʹ′-GGGTGTCTGAGTC- TTTGAAGCTGGAG-3ʹ′, 
r e v e r s e - 1 5ʹ′- A C C T G TA AT C T C C C G A C T G T- C C T G A A - 3ʹ′, r e v e r s e - 2 5ʹ′-
C G A AT T C G C C A AT G A C A A G A C G C T G G - 3 ʹ′; P e r i o s t i n f o r w a r d - 1 5 ʹ′-
TGTGGTGGCAGAGACAGAAG-3ʹ′, reverse-1 5ʹ′-CTCCCCTGTGGTGCATTTAC-3ʹ′, reverse-2 
5ʹ′-GTTGCACCACAG- ATGAAACG-3ʹ′.	

"
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Cell culture	

S16 cells were maintained in Dulbecco’s modified Eagle’s medium that had been supplemented 
with heat-inactivated 10% fetal calf serum. All cell culture reagents were purchased from Invitrogen 
unless otherwise specified. TGFβ-1 from porcine platelets as well as collagen I, collagen IV, 
collagen V and fibronectin were purchased from Sigma. NRG1 was purchased from Neomarkers, 
and Laminin-1 from Roche Applied Science. The anti- periostin antibody was an affinity purified 
polyclonal antibody from rabbit directed against the first 347 amino acids of the protein without the 
leader sequence. The monoclonal Sox10 antibody was provided by Michael Wegner (University of 
Erlangen, Germany).	

Isoform analysis	

DRG explant cultures were cultivated for 36 h, and total RNA was extracted using Trizol 
(Invitrogen). Reverse transcription was performed with Superscript II (Invitrogen) and oligo(dT) 
primer. Transcribed cDNA was amplified using periostin-specific primers F15 and R23 (forward 
p r imer 5ʹ′-CATCCACGTCGTGGACAAACTCCTC-3ʹ′, r everse p r imer 5ʹ′-T- 
TGGCTTCTGTTGGTTGTCA-3ʹ′) and purified by using agarose gel electrophoresis. The 
amplicons were isolated and then subcloned into pGemT easy vectors (Promega); the constructs 
were subsequently sequenced.	

Microarray hybridisation	

DRG explant cultures were cultivated for 36h, and total RNA was isolated using Trizol (Invitrogen), 
according to the manufacturer’s instructions. RNA was reverse transcribed using a T7-promoter-
tagged polyT primer [5ʹ′-GGCCAGTGAATTGTAATACGACTCACTATAGGGA- GGCGG-
(dT)24-3ʹ′], and antisense RNA was produced using T7 RNA polymerase. Antisense RNA was 
examined by using gel electrophoresis. Equivalent amounts of RNA from five age-matched 
embryos of the same genotype were pooled to generate a microarray probe. Probes were biotin- 
labelled in a second round of T7 amplification, as previously described (Luo et al., 1999). Profiles 
of ErbB3-deficient mice were compared with the profiles of wild-type littermates of the same 
genetic background. Microarray profiling was performed in triplicate from independent preparations 
of embryonic RNA using Affymetrix MG-U74Av2, MG-U74Bv2 and MG-U74Cv2 GeneChips 
(36,000 sequences). Data were normalized, and comparative analyses were performed using the 
statistical algorithm of Affymetrix Microarray Suite (MAS) 5.0 software following the 
manufacturer’s guidelines. Ranking and filtering of genes was performed using Microsoft Excel.	

Virtual northern blot	

Total RNA from DRG cultures was transcribed with oligo-dT primer by reverse transcriptase and 
amplified using the SMARTTM technology (Clontech) following the manufacturer’s guidelines. 
Thereafter, Southern blots were performed using the first 582 nucleotides of the periostin cDNA or 
full-length GAPDH labelled with [32P]-CTP.	

In situ hybridisation and immunohistochemistry 
Embryos were isolated at 10–16.5 dpc from staged pregnancies and fixed in 4% paraformaldehyde 
(PFA; in PBS) for 4–16 h. Samples were then equilibrated in 30% sucrose, embedded in OCT 
(Miles), frozen and sectioned using a cryostat. In situ hybridisation was performed as described 
previously (Sonnenberg et al., 1991). The first 582 nucleotides of periostin were used as periostin-
specific probe.	

For immunohistochemistry, embryos and tissues were fixed in 4% PFA in PBS at 4°C overnight, 
cryoprotected in 20% sucrose in PBS for 12 h at 4°C, embedded in OCT compound (Miles) and 
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sectioned using a cryostat (thickness of 10 μm). Sections were rinsed three times with PBS, blocked 
for 30 min with PBS containing 0.1% Triton X-100 and 0.2% bovine serum albumin (BSA) and 
incubated overnight with primary antibodies at 4°C. After being washed three times with PBS (each 
wash lasting 5 min), the sections were incubated with the appropriate secondary antibodies 
conjugated to Alexa 466 (Molecular Probes) or Cy3 (Jackson Laboratories; Chemicon) for 1 h and 
then washed. Primary mouse immunoglobulin G1 antibodies were detected with Zenon technology 
(Molecular Probes). After the sections had been rinsed with PBS and nuclei had been counterstained 
with 4ʹ′,6ʹ′-diamidino-2- phenylindole (DAPI; 0.001 mg/ml of PBS), sections were examined with a 
Zeiss Axioplan 2 microscope, and images were taken with a Zeiss AxioCam digital camera 
(Brockschnieder et al., 2004). In the case of double-labelling experiments, slides were fixed in 4% 
PFA (in PBS) for 30 min after the final wash. Then the second primary antibody was added, and the 
procedure described above was followed through again. The following antibodies were used in this 
study: anti-Sox10 (monoclonal antibody from Michael Wegner’s Lab); anti-periostin (Abcam); anti-
β-galactosidase (Cappel); anti-laminin (Lab Vision Corporation).	

Expression of recombinant proteins	

Total RNA from DRG cultures was transcribed with oligo-dT primer 5ʹ′- 
GACCACGCGTATCGATGTCGAC-(dT)16-3ʹ′ by reverse transcriptase. Periostin cDNA was 
amplified by using gene specific primers 5ʹ′-GGCT- GAAGATGGTTCCTCTC-3ʹ′ and a primer 
binding to the overhang of the oligo-dT primer (5ʹ′-GACCAGGCGTATCGATGTCGAC-3ʹ′). For 
recombinant protein expression, the cDNA was amplified with primers 5ʹ′- 
G AT C G C T A G C AT G G T T C C T C T C C T G - 3 ʹ′ a n d 5 ʹ′ - G AT C G C G G C C G C - 
CTGAGAACGGCCTTC-3ʹ′ providing NheI and NotI restriction sites, respectively. The PCR 
product was purified by using agarose gel electrophoresis and inserted into pcDNA5/FRT 
(Invitrogen) providing a 10×His and a c-Myc tag at the 3ʹ′-end. In order to generate stable lines, Flp-
In HEK-293 cells (Invitrogen) were transfected with the expression vector using jet PEI (Q BIO 
gene) following the manufacturer’s guidelines. This cell line enables the rapid generation of stable 
expression from a defined locus. The protein was purified from the supernatant by using 
immobilized metal ion affinity chromatography using Ni-NTA-matrix (Qiagen) following the 
manufacturer’s guidelines and was then dialyzed against PBS.	

Quantitative real-time PCR	

Total RNA for qRT-PCR analyses was extracted from S16 cells that had been cultured for 24 h on 
laminin-coated plates in Opti-Mem medium and subsequently stimulated with 10 ng/ml NRG1 or 1 
ng/ml TGFβ-1 for 24 h. After treatment with RNase-free DNase for 30 min at 37°C to remove 
genomic DNA, the quantity and quality of the RNA was determined by using the RNA 6000 Nano 
LabChip Kit (Agilent). The cDNA was synthesised from 3 μg of total RNA using 1 μg random 
primers with Superscript II (Invitrogen) and spiked with the amylose extender1 (ae I) gene from 
wheat. qRT-PCR was performed using the ABI PRISM 7700 (ABI). The efficiency of cDNA 
synthesis was evaluated by amplifying the ae I cDNA (ae I forward 5ʹ′-
ACGCGATGCCCTCCATAG-3ʹ′, ae I reverse 5ʹ′-AATTCGAGACCGGATCCT-3ʹ′). All reactions 
contained 15 ng cDNA, 300 nM periostin forward primer 5ʹ′-TTCCGAGAGATCATCCAACC-3ʹ′, 
50 nM periostin reverse primer 5ʹ′-AGGCTGAGGAAGATGCTGAA-3ʹ′ (product size 82 bp), 18S 
60 nM forward primer 5ʹ′-CGGCTACCACATCC- AAGAA-3ʹ′, 18S 60 nM reverse primer 5ʹ′-
GCTGGAATTACCGCGGCT-3ʹ′ (product size 182 bp) and QPCR Mastermix for SYBR® Green I 
(Eurogentec) in a final volume of 20 μl. Primer concentrations and conditions were optimised in 
preliminary experiments. The thermal profile started with an initial step of 50°C for 2 min, followed 
by 10 min 95°C to activate the polymerase and subsequently 40 cycles each comprising 15 s 95°C 
and 1 min 65°C. In each analysis, all samples were run in parallel. The control gene selected to 
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normalize each sample for RNA content was 18S ribosomal RNA. The fold difference was analysed 
by using the standard deviation calculations using the relative standard curve method. The paired 
sample t-test was used to evaluate the significance of differences in expression in paired groups.	

Western blot analysis and immunoprecipitation	

Cells were washed twice with ice-cold PBS and lysed with a buffer containing 50 mM Tris-HCl 
( pH 7.4), 150 NaCl, 1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride and a protease 
inhibitor cocktail (Complete mini, Roche). Protein extracts or purified protein were separated by 
using SDS-PAGE, transferred to PVDF membrane (Millipore), blocked with 5% milk powder in 
PBS and incubated with the indicated antibodies overnight. Immunoreactive bands were visualized 
by using chemiluminescence (Millipore). For immunoprecipitation, the HEK-293 cells were 
transfected with a plasmid expressing periostin or β-galactosidase. Laminin was added to the cell 
culture medium and, at 24 h after transfection, the supernatant was collected and precleared with 
protein-G/A–Sepharose (Santa Cruz Biotechnology) for 2 h at 4°C. The pre-cleared supernatant was 
incubated with anti-laminin antibody (1:100) (Clone A5, NeoMarkers) overnight. The 
immunocomplex was extensively washed, the samples (30μg) were subjected to immunoblotting, 
and periostin was detected with anti-c-Myc antibody (clone 9E10, Sigma).	

Solid-phase assay	

96-well plates (Nunc) were coated overnight with 100 μg/ml of collagen I, collagen IV, collagen V, 
fibronectin, bovine serum albumin fraction V (Sigma) and laminin (Roche). After blocking with 5% 
milk powder in 100 mM Tris-HCl pH 7.5, 150 mM NaCl, 200 ng/ml of recombinantly expressed 
and purified periostin was incubated for 5 h in 100 mM Tris-HCl pH 7.5, 150 mM NaCl or 100 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 2 mM CaCl2. Periostin was detected using an anti-c-Myc 
horseradish peroxidase (HRP) conjugate. The immunoreactivity was visualized by using ABTS as a 
substrate and measured at 405 nm.	

Migration analysis	

For the migration assay, HEK-293 cells were transfected for 36 h with plasmid encoding periostin 
or β-galactosidase. The conditioned medium was collected and filtered. Additionally, HEK-293 
cells were transfected for 24 h with plasmids encoding periostin or EGFP. 1×105 of these cells were 
then transferred onto 8-μm pore polycarbonate filter (Nunc). The lower chamber of Transwell 
inserts was loaded with the conditioned medium. After 24 h of incubation, the top cells on the 
Transwell membrane were removed using Q-tips. The cells trapped by the membrane were fixed 
and stained with Diff-Quick (Düdingen, Switzerland). Cell numbers within the entire membrane 
area were determined.	

For the analyses of Schwann cell migration, DRG explant cultures were cultured for 72 h and were 
then analysed by immunofluorescence using an antibody against Sox10 and the Neurofilament 200 
antibody (Sigma) to visualise Schwann cells and axons, respectively. All migrating Sox10- positive 
cells per DRG were counted.	

BrdU incorporation in cultured DRG	

The DRG explant cultures were cultured for 48 h and incubated for 1 h with 10 μM BrdU, washed 
with PBS and fixed for 20 min with Carnoy’s fixative (methanol and acetic acid, 3:1) at −20°C. 
Subsequently, the DRG cultures were incubated for 15 min with 2.4 M HCl at 37°C. To identify 
incorporated BrdU, thus proliferating cells, an antibody against BrdU (Roche) was used.	
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TUNEL staining	

The DRG were cultured for 48 h and fixed with 1% PFA (in PBS) for 10 min at room temperature. 
To identify apoptotic cells, the ApopTag Apoptosis detection kit (Q-BIOgene) was used following 
the manufacturer’s guidelines.	

Statistical analysis	

In all experiments, appropriate statistical analysis (ANOVA, t-test) was performed using GraphPad 
Prism 4 or MiniTab (Release 15) software. Data are shown as mean values with standard errors of 
the mean.	
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